Загрузка...
Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey
BACKGROUND: The Icatibant Outcome Survey (IOS; NCT01034969) is a Shire‐sponsored, international, observational study monitoring the safety and effectiveness of icatibant, a bradykinin B2 receptor antagonist approved for the acute treatment of adults with hereditary angioedema with C1 inhibitor defic...
Сохранить в:
| Опубликовано в: : | J Eur Acad Dermatol Venereol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587717/ https://ncbi.nlm.nih.gov/pubmed/30176179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.15232 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|